Automated Control of Oxygen Therapy: A State-of-the-Art Review of Closed-Loop Devices, with a Rule-Based, Network-Independent System (EMILY) as a Working Exemplar

Supplemental oxygen is among the most widely administered hospital therapies, yet it remains one of the least precisely controlled. Both hypoxemia and hyperoxemia are independently associated with adverse outcomes, and the decade of pragmatic oxygen-target trials has shifted attention from the numeric choice of target toward the fidelity with which any chosen target is sustained. Manual titration is intrinsically episodic and cannot close this fidelity gap, particularly outside high-intensity monitored environments. Automated closed-loop oxygen control has matured rapidly across four delivery paradigms—conventional oxygen flow (low-to-moderate flow up to 15–20 L/min via nasal cannula or mask), high-flow nasal cannula, invasive ventilation, and neonatal respiratory support—with consistent gains in time-in-target and reductions in extremes of oxygenation across all classes. This review surveys the contemporary device landscape (FreeO2, O2matic, iPOC, the Hamilton O2 assist controller evaluated in the HILOOP study, and the TSF high-flow controller, INTELLiVENT-ASV, and the neonatal CLiO2/OxyGenie/PRICO/SPOC/IntellO2/CLAC family), compares control architectures (proportional-integral-derivative, rule-based, and emerging machine-learning approaches), and synthesizes the efficacy, safety, workload, and economic evidence. We then use EMILY, a rule-based, network-independent, source-agnostic, closed-loop flow controller deployed in an intermediate respiratory care unit as a working exemplar to illustrate where the field is heading: multi-parameter inference, network-independent operation, portability across oxygen sources, and instrumented clinician override. We discuss its specific advantages and limitations in detail, and close with an agenda for the outcome trials, interoperability standards, and equity safeguards the field now requires.

Authors

Institutions

Publication Details

Journal
Seminars in Respiratory and Critical Care Medicine
Published
2026-11-20
DOI
https://doi.org/10.1055/a-2996-0743
Primary Topic
Respiratory Support and Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Automated Control of Oxygen Therapy: A State-of-the-Art Review of Closed-Loop Devices, with a Rule-Based, Network-Independent System (EMILY) as a Working Exemplar

Itziar Fernández Ormaechea, María del Pilar Carballosa de Miguel, Sarah Béatrice Heili-Frades, Antoní Torres et al.
Seminars in Respiratory and Critical Care Medicine
Respiratory Support and Mechanisms
article

Automated Control of Oxygen Therapy: A State-of-the-Art Review of Closed-Loop Devices, with a Rule-Based, Network-Independent System (EMILY) as a Working Exemplar

Itziar Fernández Ormaechea, María del Pilar Carballosa de Miguel, Sarah Béatrice Heili-Frades, Antoní Torres, Marta Serrano, Daniel Oliva, Maria Mercedes Morante, Alba Naya Prieto
article en

Abstract

Supplemental oxygen is among the most widely administered hospital therapies, yet it remains one of the least precisely controlled. Both hypoxemia and hyperoxemia are independently associated with adverse outcomes, and the decade of pragmatic oxygen-target trials has shifted attention from the numeric choice of target toward the fidelity with which any chosen target is sustained. Manual titration is intrinsically episodic and cannot close this fidelity gap, particularly outside high-intensity monitored environments. Automated closed-loop oxygen control has matured rapidly across four delivery paradigms—conventional oxygen flow (low-to-moderate flow up to 15–20 L/min via nasal cannula or mask), high-flow nasal cannula, invasive ventilation, and neonatal respiratory support—with consistent gains in time-in-target and reductions in extremes of oxygenation across all classes. This review surveys the contemporary device landscape (FreeO2, O2matic, iPOC, the Hamilton O2 assist controller evaluated in the HILOOP study, and the TSF high-flow controller, INTELLiVENT-ASV, and the neonatal CLiO2/OxyGenie/PRICO/SPOC/IntellO2/CLAC family), compares control architectures (proportional-integral-derivative, rule-based, and emerging machine-learning approaches), and synthesizes the efficacy, safety, workload, and economic evidence. We then use EMILY, a rule-based, network-independent, source-agnostic, closed-loop flow controller deployed in an intermediate respiratory care unit as a working exemplar to illustrate where the field is heading: multi-parameter inference, network-independent operation, portability across oxygen sources, and instrumented clinician override. We discuss its specific advantages and limitations in detail, and close with an agenda for the outcome trials, interoperability standards, and equity safeguards the field now requires.

Seminars in Respiratory and Critical Care Medicine
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES), Hospital Clínic de Barcelona (ES), Hospital Universitario Fundación Jiménez Díaz (ES), Universidad Alfonso X el Sabio (ES), Universidad Autónoma de Madrid (ES)
Good health and well-being
Respiratory Support and Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon